| Parathyroid hormone-related |
| Primary hyperparathyroidism* |
| Sporadic, familial, associated with multiple endocrine neoplasia I or II |
| Tertiary hyperparathyroidism |
| Associated with chronic renal failure or vitamin D deficiency |
| Vitamin D-related |
| Vitamin D intoxication |
| Usually 25-hydroxyvitamin D2 in over-the-counter supplements |
| Granulomatous disease sarcoidosis, berylliosis, tuberculosis |
| Hodgkin's lymphoma |
| Malignancy |
| Humoral hypercalcemia of malignancy* (mediated by PTHrP) |
| Solid tumors, especially lung, head, and neck squamous cancers, renal cell tumors |
| Local osteolysis* (mediated by cytokines) multiple myeloma, breast cancer |
| Medications |
| Thiazide diuretics (usually mild)* |
| Lithium |
| Milk-alkali syndrome (from calcium antacids) |
| Vitamin A intoxication (including analogs used to treat acne) |
| Other endocrine disorders |
| Hyperthyroidism |
| Adrenal insufficiency |
| Acromegaly |
| Pheochromocytoma |
| Genetic disorders |
| Familial hypocalciuric hypercalcemia: mutated calcium-sensing receptor |
| Other |
| Immobilization, with high bone turnover (e.g., Paget's disease, bedridden child) |
| Recovery phase of rhabdomyolysis |